ClinicalTrials.Veeva

Menu

Perioperative Opioid-induced Hyperalgesia and Its Prevention With Ketamine and Methadone

F

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Status

Completed

Conditions

Hyperalgesia
Post Operative Pain

Treatments

Drug: ketamine infusion
Drug: Methadone PCA

Study type

Interventional

Funder types

Other

Identifiers

NCT01594047
metadone

Details and patient eligibility

About

Background: In perioperative period inhibition of N-Methyl-D-Aspartate receptor prevents opioid-induced hyperalgesia and reduce postoperative opioid requirement after abdominal surgery. Methadone is both a µ-opioid receptor agonist like Morphine and a N-Methyl-D-Aspartate antagonist. Study Aim. To evaluate the efficacy of intraoperative Ketamine and postoperative Methadone analgesia in preventing opioid-induced hyperalgesia after abdominal surgery.

Full description

not desired

Enrollment

113 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients undergoing open colo-rectal surgery

Exclusion criteria

  • ASA status more than II, history of chronic pain, ischemic heart disease or chronic pulmonary disease, allergy to any drugs used in the protocol. Body Max Index more than 35.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

113 participants in 4 patient groups

zero/morphine
No Intervention group
Description:
Patient received a standard balance anaesthesia and morphine for post operative pain.
ketamine/morphine
Experimental group
Description:
Ketamine infusion scheme: 5mcg/Kg/min from induction od anaesthesia for 10 min, than 2,5mcg/Kg/min for 20 min and than 2 mcg/Kg/min to the end of surgery.
Treatment:
Drug: ketamine infusion
zero/metadone
Experimental group
Description:
Methadone PCA
Treatment:
Drug: Methadone PCA
ketamine/methadone
Experimental group
Description:
Ketamine infusion scheme: 5mcg/Kg/min from induction od anaesthesia for 10 min, than 2,5mcg/Kg/min for 20 min and than 2 mcg/Kg/min to the end of surgery. Methadone administered by a PCA system (dose 2 mg, lock-out 12min.).
Treatment:
Drug: Methadone PCA
Drug: ketamine infusion

Trial contacts and locations

1

Loading...

Central trial contact

Emiliano Tognoli; Langer Martin

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems